Gad Soffer, EVP & Chief Strategy Officer at Atara Biotherapeutics, Inc. (ATRA), sold 12,148 shares at $15.42 ($188K) on 2017-02-10, disclosed to the SEC on 2017-02-13.
Open-market sale of $188k ATRA by EVP & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.42 | 5,874 | $91K | 48.3% |
| 2 | $15.42 | 5,874 | $91K | 48.3% |
| 3 | $16.13 | 400 | $6K | 3.4% |
| Total | $15.44 avg | 12,148 | $188K | 100% |
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |